Skip to main navigation Skip to search Skip to main content

Lipid and biomarker differences between Raltegravir and Atazanavir/Ritonavir at 48 Weeks in the Raltegravir Atazanavir Naïve (RAN) study

  • Tanvir Bell
  • , Martine Diez
  • , Xiaoying Yu
  • , Chi Nguyen
  • , Claudia Kozinetz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Lipid and biomarker differences between Raltegravir and Atazanavir/Ritonavir at 48 Weeks in the Raltegravir Atazanavir Naïve (RAN) study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology